|
Volumn 54, Issue 1, 2006, Pages 381-382
|
Anti-tumor necrosis factor α therapy and the risk of JC virus infection [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CYTOKINE;
ETANERCEPT;
IMMUNOMODULATING AGENT;
INFLIXIMAB;
NATALIZUMAB;
RITUXIMAB;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ARTHRITIS;
BONE MARROW TRANSPLANTATION;
BRAIN BIOPSY;
CROHN DISEASE;
DEMYELINATION;
DISEASE PREDISPOSITION;
HUMAN;
JC VIRUS;
LETTER;
LEUKOCYTE MIGRATION;
MULTIPLE SCLEROSIS;
PRIORITY JOURNAL;
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;
RHEUMATIC DISEASE;
VIRUS INFECTION;
ANTIBODIES, MONOCLONAL;
HUMANS;
INTEGRIN ALPHA4;
LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL;
RISK FACTORS;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 31044435632
PISSN: 00043591
EISSN: None
Source Type: Journal
DOI: 10.1002/art.21688 Document Type: Letter |
Times cited : (13)
|
References (7)
|